The Rise of Women-Powered Economies: GPWF Cambridge 2026 Positions Women Leaders at the Centre of Capital, Trade and Economic Governance Can the World End Obstetric Fistula and Restore Dignity for Women? Women in Blue Helmets: The Growing Force Transforming Global Peacekeeping She Faced Rejection and Still Rose: The Inspiring Journey of Sibongile Sambo Raising Confident Girls in a Globalised World Exploring Culture through Travel: Why Every Woman Should Experience Africa

Isobel Coleman Takes the Helm as CEO of the Alzheimer’s Drug Discovery Foundation

By Blossom Ukoha “I’m honored to be announced as the next CEO of the Alzheimer’s Drug Discovery Foundation. Alzheimer’s is one of the defining health challenges of our time, but we are living in a moment of real progress. The clinical pipeline is expanding, blood-based diagnostics are changing how we detect disease, and advances in AI are helping accelerate the pace of discovery. Together with growing evidence around prevention, there is new momentum in the field and real reason for hope.” With this statement, Isobel Coleman sets the tone for her new role as Chief Executive Officer of the Alzheimer’s Drug Discovery Foundation, which took effective March 23, 2026. Her appointment comes at a critical moment as Alzheimer’s research enters a phase of accelerated scientific progress. Coleman brings extensive leadership experience across government, private sector, and nonprofit institutions. Most recently, she served as Deputy Administrator of the U.S. Agency for…